Shigeyuki Chaki

This inventor holds 15 USPTO granted patents, plus 4 CIPO patents and 1 EPO patent. Top assignees: Taisho Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd., Other. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeyuki Chaki. Retrieved from https://idiyas.com/inventor/shigeyuki-chaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 60.0

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 68(Granted Patents)

Location History:

Saitama, JP (2005)
Tokyo, JP (2000 - 2007)
Toshima-ku, JP (2011 - 2012)

Company Filing History:

7 out of 314

Taisho Pharmaceutical Co., Ltd.

patents

1 out of 183

Nihon Nohyaku Co., Ltd.

patents

8 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2012

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8193176 - Phenylpyrazole derivatives (2012-06-05),

2. 8183387 - Phenylpyrazole derivatives (2012-05-22),

3. 7888354 - Phenylpyrazole derivatives (2011-02-15),

4. 7157594 - 6-Fluorobicyclo[3.1.0]hexane derivatives (2007-01-02),

5. 6949552 - Remedial agent for anxiety neurosis or depression and piperazine derivative (2005-09-27),

6. 6806275 - Arylpiperidine derivatives and use thereof (2004-10-19),

7. 6476056 - Heterocycle substituted aryloxyaniline derivatives and their use as MDR ligands (2002-11-05),

8. 6407121 - Arylpiperidine derivatives and use thereof (2002-06-18),

9. 6380384 - 1,2-dihydro-2-oxoquinoline derivatives (2002-04-30),

10. 6333358 - Aryloxyaniline derivatives (2001-12-25),

11. 6329525 - 1,2-Dihydro-2-oxoquinoline derivatives (2001-12-11),

12. 6291467 - Heteroaromatic derivatives (2001-09-18),

13. 6281355 - Nitrogen-containing tetracyclic compounds (2001-08-28),

14. 6187781 - 4-Tetrahydropyridylpyrimidine derivatives (2001-02-13),

15. 6166033 - 2-carbonylthiazole derivatives and use of the same (2000-12-26),

Title: Shigeyuki Chaki: Innovator in Pharmaceutical Development

Introduction

Shigeyuki Chaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for various mental and physical health conditions. With a total of 15 patents to his name, Chaki's work has the potential to impact many lives.

Latest Patents

Among his latest innovations are phenylpyrazole derivatives, which serve as prophylactic or therapeutic agents for a range of conditions including dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, and allergic rhinitis. These derivatives are represented by a specific formula, which includes pharmaceutically acceptable salts.

Career Highlights

Chaki has worked with notable companies in the pharmaceutical industry, including Taisho Pharmaceutical Co., Ltd. His expertise in drug development has positioned him as a key figure in the advancement of treatments for complex health issues.

Collaborations

Throughout his career, Chaki has collaborated with esteemed colleagues such as Atsuro Nakazato and Kazuyuki Tomisawa. These partnerships have fostered innovation and have contributed to the success of his projects.

Conclusion

Shigeyuki Chaki's contributions to pharmaceutical innovations highlight his dedication to improving health outcomes through research and development. His work continues to pave the way for new therapeutic options in the medical field.

Profile summary based on public USPTO records.